Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PYPL vs MRNA✓SelectedUSD · MRNAPYPL vs MRNA performance historyLatest closeAs of-0.76%11/16
Stock and ETF performance explorer

PYPL vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-28.1%
MRNA return
+878.5%
Excess return
-906.6%
Maximum drawdown
-87.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-0.8%-3.6%+2.9%-0.5%
7D-2.0%-20.0%+17.9%-0.6%
30D+3.8%-1.3%+5.0%+3.6%
3M-4.4%+240.0%-244.3%-17.1%
6M+33.2%+339.0%-305.7%+11.4%
YTD+1.7%+630.0%-628.3%-20.5%
1Y-5.3%+769.1%-774.4%-27.6%
3Y+4.7%+181.2%-176.5%-13.0%
5Y-72.4%-8.1%-64.3%-75.5%
All-28.1%+878.5%-906.6%-37.7%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling